Tag Archives: mantle cell lymphoma

Phase I/II Clinical Trial of Copanlisib and Ibrutinib in Mantle Cell Lymphoma

Share

A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma

Memorial Sloan Kettering Cancer Center / Bayer
ClinicalTrials.gov Identifier: NCT03877055

Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center [Photo: National Cancer Institute]
Investigators at Memorial Sloan Kettering Cancer Center have opened a Phase I/II clinical trial to test the safety and any positive and negative side effects of combining two study drugs, copanlisib (ALIQOPATM, Bayer) and ibrutinib (IMBRUVICA®, Pharmacyclics, Janssen Biotech), in the treatment of mantle cell lymphoma.

See additional details, including study location(s), eligibility criteria, contact information, and study results (when available) at ClinicalTrials.gov.

Send email to avery@williamaveryhudson.com for information about submitting qualified clinical trials for sponsored posts on this blog.




The information on my blog is not intended as a substitute for medical professional help or advice but is to be used only as an aid in understanding current medical knowledge. A physician should always be consulted for any health problem or medical condition.